CJC1295 with DAC

CJC1295 with DAC (Drug Affinity Complex) is a synthetic analog of Growth Hormone Releasing Hormone (GHRH) designed for extended biological activity. The addition of the DAC moiety allows the peptide to bind to plasma albumin after administration, which dramatically increases its half-life from a few minutes to several days. This enables a steady, continuous stimulation of the pituitary gland to release endogenous growth hormone (GH), which in turn leads to a sustained elevation of Insulin-like Growth Factor 1 (IGF-1). This makes it a highly valuable subject for research into long-term growth hormone deficiency, muscle preservation, and anti-aging.

Scientific interest in CJC1295 with DAC focuses on its ability to promote fat loss, increase lean muscle mass, and improve recovery without the “spiking” effects associated with shorter-acting compounds. Because it maintains a stable level of GH secretion, it is researched for its potential to improve sleep quality, enhance skin elasticity, and support overall cellular repair. However, researchers also study the “bleed” effect of continuous GH stimulation to understand the long-term impacts on the endocrine system. As a highly purified research tool, CJC1295 with DAC provides a unique model for investigating how long-acting secretagogues can optimize growth hormone levels and influence systemic rejuvenation and metabolic efficiency.